The nicotinergic receptor as a target for cognitive enhancement in schizophrenia: Barking up the wrong tree?

Psychopharmacology

Volumn 231, Issue 3, 2014, Pages 543-550

  Quisenaerts, C ^a   Morrens, M ^a,b   Hulstijn, W ^a   De Bruijn, E ^a,c   Timmers, M ^d   Streffer, J ^d   De La Asuncion, J ^a   Dumont, G ^a,e   Sabbe, B ^a,e  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Psychiatric Center Brothers   (Belgium)

^c LEIDEN UNIVERSITY   (Netherlands)

^d JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^e University Psychiatric Center St Norbertushuis   (Belgium)

Author keywords

Attention; Cognition; Cognitive enhancement; Nicotine; Schizophrenia; Social cognition

Indexed keywords

NICOTINE; NICOTINE GUM; NICOTINIC RECEPTOR; NICOTINIC AGENT; NOOTROPIC AGENT;

ADULT; ARTICLE; ATTENTION; BRAIN FUNCTION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; METHODOLOGY; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SMOKING; SOCIAL BEHAVIOR; WORKING MEMORY; BLOOD; COGNITION DISORDERS; CROSSOVER PROCEDURE; DRUG EFFECTS; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; STATISTICAL MODEL;

ADULT; COGNITION DISORDERS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LINEAR MODELS; MALE; NEUROPSYCHOLOGICAL TESTS; NICOTINE; NICOTINIC AGONISTS; NOOTROPIC AGENTS; PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SMOKING;

EID: 84892826696     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3264-9     Document Type: Article

References (36)

1. AhnAllen CG, Nestor PG, Shenton ME, McCarley RW, Niznikiewicz MA (2008) Early nicotine withdrawal and transdermal nicotine effects on neurocognitive performance in schizophrenia. Schizophr Res 100:261-269
2. Barak S, Weiner I (2011) Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target. Pharmacol, Biochem Behav 99:164-189
3. Baron-Cohen S, Wheelwright S, Hill J, Raste Y, Plumb I (2001) The Reading the Mind in the Eyes Test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism. J Child Psychol Psychiatry 42:241-251
4. Barr RS, Culhane MA, Jubelt LE et al (2008) The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacol 33:480-490
5. Brody AL, Mandelkern MA, London ED, Olmstead RE, Farahi J, Scheibal D et al (2006) Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Arch Gen Psychiatry 63:907-915
6. Cornblatt BA, Risch N, Faris G, Friedman D, Erlenmeyer-Kimling L (1988) The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatr Res 26:223-238
7. D'Souza MS, Markou A (2012) Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits. Neuropharmacol 62:1564-1573
8. Dépatie L, O'Driscoll GA, Holahan AL et al (2002) Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study. Neuropsychopharmacol 27:1056-1070
9. Docx L, Morrens M, Bervoets C, Hulstijn W, Fransen E, De Hert M, Baeken C, Audenaert K, Sabbe B (2012) Parsing the components of the psychomotor syndrome in schizophrenia. Acta Psychiatr Scand 126:256-265
10. Drusch K, Lowe A, Fisahn K, Brinkmeyer J, Musso F, Mobascher A, Warbrick T, Shah J, Ohmann C, Winterer G, Wölwer W (2013) Effects of nicotine on social cognition, social competence and self-reported stress in schizophrenia patients and healthy controls. Eur Arch Psychiatry Clin Neurosci 263(6):519-527
11. Freedman R, Olincy A, Buchanan RW, Harris JG, Gold JM, Johnson L et al (2008) Initial phase 2 trial of a nicotinic agonist in schizophrenia. Am J Psychiatry 165:1040-1047
12. Goff DC, Hill M, Barch D (2011) The treatment of cognitive impairment in schizophrenia. Pharmacol, Biochem Behav 99:245-253
13. Green MF, Kern RS, Heaton RK (2004) Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res 15:41-51
14. Houthoofd SA, Morrens M, Sabbe BG (2008) Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder. Clin Ther 30:1565-1589
15. Harris JG, Kongs S, Allensworth D, Martin L, Tregellas J, Sullivan B et al (2004) Effects of nicotine on cognitive deficits in schizophrenia. Neuropsychopharmacol 29:1378-1385
16. Hong LE, Schroeder M, Ross TJ, Buchholz B, Salmeron BJ, Wonodi I et al (2011a) Nicotine enhances but does not normalize visual sustained attention and the associated brain network in schizophrenia. Schizophr Bull 37:416-425
17. Hong LE, Thaker GK, McMahon RP, Summerfelt A, Rachbeisel J, Fuller RL et al (2011b) Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 68:1195-1206
18. Ibrahim HM, Tamminga CA (2012) Treating impaired cognition in schizophrenia. Curr Pharm Biotechnol 13:1587-1594
19. Jacobsen LK, D'Souza DC, Mencl WE, Pugh KR, Skudlarski P, Krystal JH (2004) Nicotine effects on brain function and functional connectivity in schizophrenia. Biol Psychiatry 55:850-858
20. Jubelt LE, Barr RS, Goff DC, Logvinenko T, Weiss AP, Evins AE (2008) Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia. Psychopharmacol 199:89-98
21. Levin ED, Wilson W, Rose JE, McEvoy J (1996) Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacol 15:429-436
22. Mansvelder HD, van Aerde KI, Couey JJ, Brussaard AB (2006) Nicotinic modulation of neuronal networks: from receptors to cognition. Psychopharmacol 184:292-305
23. Morrens M, Hulstijn W, Lewi P, Sabbe B (2008a) Bleuler revisited: psychomotor slowing in schizophrenia as part of a catatonic symptom cluster. Psychiatry Res 30:121-125
24. Morrens M, Hulstijn W, Matton C, Madani Y, van Bouwel L, Peuskens J, Sabbe BG (2008b) Delineating psychomotor slowing from reduced processing speed in schizophrenia. Cogn Neuropsychiatry 13:457-471
25. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK (2004) Identification of separable cognitive factors in schizophrenia. Schizophr Res 15:29-39
26. Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D et al (2006) Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry 63:630-638
27. Quisenaerts C, Morrens M, Sabbe B (2013) De nicotine receptor als target voor verbetering van de cognitieve symptomen bij schizofrenie. Tijdschr Psychiatr 55:415-425
28. Sacco KA, Termine A, Seyal A, Dudas MM, Vessicchio JC, Krishnan-Sarin S et al (2005) Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry 62:649-659
29. Sherr JD, Myers C, Avila MT, Elliott A, Blaxton TA, Thaker GK (2002) The effects of nicotine on specific eye tracking measures in schizophrenia. Biol Psychiatry 52:721-728
30. Shim JC, Jung DU, Jung SS, Seo YS, Cho DM, Lee JH et al (2012) Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial. Neuropsychopharmacol 37:660-668
31. Sivan A (1992) Benton Visual Retention Test, 5th edn. The Psychological Corporation, San Antonio
32. Smith RC, Singh A, Infante M, Khandat A, Kloos A (2002) Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. Neuropsychopharmacol 27:479-497
33. Smith RC, Warner-Cohen J, Matute M et al (2006) Effects of nicotine nasal spray on cognitive function in schizophrenia. Neuropsychopharmacol 31:637-644
34. Velligan D, Brenner R, Sicuro F et al (2012) Assessment of the effects of AZD3480 on cognitive function in patients with schizophrenia. Schizophr Res 134:59-64
35. Wechsler D (1981) Manual for the Wechsler Adult Intelligence Scale-Revised. Psychological Corporation, San Antonio
36. Winterer G (2010) Why do patients with schizophrenia smoke? Curr Opin Psychiatry 23:112-119